36:
277:, founded PHARMAGIAN in 1960, a company that acted as a representative of major international pharmaceutical companies in Greece. Two decades of expansion followed and in 1971 the company became a societe anonyme (S.A.), changing its name to VIANEX, while in 1977 it began its manufacturing activities with the establishment of the first manufacturing plant in the Athens area.
238:(Japan). VIANEX S.A. has also been exporting registered products for over 20 years in 35 countries in Europe (UK, France, Spain, Germany, Denmark, Netherlands, Cyprus), the Middle East (Jordan, S. Arabia), Africa (Tunisia, Sudan, South Africa, the Ivory Coast) and Asia (Philippines, Japan, Vietnam, Singapore, Taiwan).
256:
VIANEX S.A. has also established its own
Research & Development department, which undertakes the development of new pharmaceutical formulations for the treatment of various medicinal causes. The company recently began to cooperate with various universities on the research and development of new
225:
The company produces, imports, packages, markets and distributes a large number of pharmaceuticals covering all the various therapeutic classes. It has also formed strategic partnerships and alliances with major pharmaceutical entities across the globe, such as
318:, including Gastroenterology, Hypertension, Cholesterol, Dermatological, Osteoporosis, Antibiotics, Vaccines, Blood derivatives, Oncology, Anti-inflammatories, Neurology/Psychiatry, Urology, Asthma and Eye care.
283:
In 1995, developments and the growth of the over-the-counter (O.T.C.) sector led to VIANEX S.A. founding VIAN S.A., in order to distribute its O.T.C. pharmaceutical and non-pharmaceutical products.
290:, focusing on the manufacture of certain antibiotics. In 2006, VIANEX established a Research & Development spin-off company, ELDRUG S.A., which bases its work on the research findings of the
493:
498:
280:
A second plant was obtained from the
Winthrop-Sterling company in 1983 in the Pallini region of Athens, while a third plant was added in VIANEX’s roster in 1985.
488:
483:
286:
The company’s expansion in various sectors of the pharmaceutical industry called for a fourth plant in 1999, this time in the industrial area of
235:
222:
pharmaceutical company, founded in 1971 by the
Giannakopoulos’ family that has been involved with the pharmaceutical industry since 1924.
141:
27:
35:
298:
266:
122:
52:
84:
478:
274:
80:
291:
405:
394:
383:
372:
361:
461:
ExportLeaders.gr VIANEX S.A. Synonymous with the history of the Greek pharmaceutical industry.
450:
ExportLeaders.gr VIANEX S.A. Synonymous with the history of the Greek pharmaceutical industry.
439:
ExportLeaders.gr VIANEX S.A. Synonymous with the history of the Greek pharmaceutical industry.
417:
ExportLeaders.gr VIANEX S.A. Synonymous with the history of the Greek pharmaceutical industry.
460:
449:
438:
416:
177:
270:
231:
227:
215:
62:
472:
265:
VIANEX’s origins date back to 1924, when
Dimitrios Giannakopoulos, grandfather of
153:
257:
active molecules which are effective in the treatment of serious diseases.
427:
273:. After accumulating decades of family experience in the field, his son,
26:
287:
250:
246:
242:
219:
100:
96:
41:
165:
406:
https://www.vianex.gr/img/financial/2017/enopoihmenos2017.pdf
395:
https://www.vianex.gr/img/financial/2017/enopoihmenos2017.pdf
384:
https://www.vianex.gr/img/financial/2017/enopoihmenos2017.pdf
373:
https://www.vianex.gr/img/financial/2017/enopoihmenos2017.pdf
362:
https://www.vianex.gr/img/financial/2017/enopoihmenos2017.pdf
304:
In 2019, VIANEX acquired
Pharmanel pharmaceutical company.
312:
VIANEX products cover the following therapeutic classes:
202:
269:, opened one of the first pharmacy stores in Athens, in
245:, Greece, while the company owns three factories in the
297:In 2011, VIANEX became an approved supplier by the
197:
187:
175:
163:
151:
139:
131:
116:
106:
92:
76:
68:
58:
48:
40:VIANEX S.A. Factory D in the Industrial zone of
294:and on the University’s technical expertise.
8:
494:Pharmaceutical companies established in 1971
19:
34:
18:
499:Manufacturing companies based in Athens
354:
324:, such as analgesics and antiseptics
236:Takeda Pharmaceutical Company Limited
7:
489:Greek companies established in 1971
484:Pharmaceutical companies of Greece
14:
345:, such as skin care products etc
241:The headquarters are located in
25:
1:
16:Greek pharmaceutical company
515:
299:World Health Organization
33:
24:
267:Dimitrios Giannakopoulos
123:Dimitrios Giannakopoulos
328:Nutritional Supplements
183:€129.18 million (2017)
85:Thanasis Giannakopoulos
322:Non-Prescription (OTC)
171:€171.47 million (2017)
147:€45.041 million (2017)
135:€236.31 million (2017)
275:Pavlos Giannakopoulos
159:€4.491 million (2017)
88:Kostas Giannakopoulos
81:Pavlos Giannakopoulos
292:University of Patras
218:: Βιανεξ Α.Ε.) is a
126:(Chairman & CEO)
189:Number of employees
21:
249:region and one in
428:Vianex.gr Exports
316:Prescription (RX)
234:MSD (France) and
209:
208:
506:
463:
458:
452:
447:
441:
436:
430:
425:
419:
414:
408:
403:
397:
392:
386:
381:
375:
370:
364:
359:
333:Infant Nutrition
205:
180:
168:
142:Operating income
38:
29:
22:
514:
513:
509:
508:
507:
505:
504:
503:
469:
468:
467:
466:
459:
455:
448:
444:
437:
433:
426:
422:
415:
411:
404:
400:
393:
389:
382:
378:
371:
367:
360:
356:
351:
310:
271:Peiraios Street
263:
228:Merck & Co.
201:
190:
176:
164:
156:
144:
119:
109:
87:
83:
44:
17:
12:
11:
5:
512:
510:
502:
501:
496:
491:
486:
481:
471:
470:
465:
464:
453:
442:
431:
420:
409:
398:
387:
376:
365:
353:
352:
350:
347:
309:
306:
262:
259:
232:Sanofi Pasteur
207:
206:
199:
195:
194:
191:
188:
185:
184:
181:
173:
172:
169:
161:
160:
157:
152:
149:
148:
145:
140:
137:
136:
133:
129:
128:
120:
117:
114:
113:
110:
107:
104:
103:
94:
90:
89:
78:
74:
73:
70:
66:
65:
63:Pharmaceutical
60:
56:
55:
50:
46:
45:
39:
31:
30:
15:
13:
10:
9:
6:
4:
3:
2:
511:
500:
497:
495:
492:
490:
487:
485:
482:
480:
477:
476:
474:
462:
457:
454:
451:
446:
443:
440:
435:
432:
429:
424:
421:
418:
413:
410:
407:
402:
399:
396:
391:
388:
385:
380:
377:
374:
369:
366:
363:
358:
355:
348:
346:
344:
340:
339:
335:
334:
330:
329:
325:
323:
319:
317:
313:
307:
305:
302:
300:
295:
293:
289:
284:
281:
278:
276:
272:
268:
260:
258:
254:
252:
248:
244:
239:
237:
233:
229:
223:
221:
217:
213:
204:
200:
196:
192:
186:
182:
179:
174:
170:
167:
162:
158:
155:
150:
146:
143:
138:
134:
130:
127:
124:
121:
115:
111:
105:
102:
98:
95:
91:
86:
82:
79:
75:
71:
67:
64:
61:
57:
54:
51:
47:
43:
37:
32:
28:
23:
479:Greek brands
456:
445:
434:
423:
412:
401:
390:
379:
368:
357:
342:
341:
337:
336:
332:
331:
327:
326:
321:
320:
315:
314:
311:
303:
296:
285:
282:
279:
264:
255:
240:
224:
211:
210:
193:1,070 (2015)
178:Total equity
166:Total assets
125:
93:Headquarters
53:Incorporated
49:Company type
338:Diagnostics
212:Vianex S.A.
108:Area served
20:Vianex S.A.
473:Categories
349:References
253:, Greece.
230:(U.S.A.),
154:Net income
118:Key people
343:Cosmetics
203:vianex.gr
112:Worldwide
308:Products
59:Industry
261:History
198:Website
132:Revenue
77:Founder
69:Founded
288:Patras
251:Patras
247:Attica
243:Athens
101:Greece
97:Athens
42:Patras
220:Greek
216:Greek
72:1971
475::
301:.
99:,
214:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
